MA MAXHEALTH
Max Healthcare Institute Q3 2026
MAMAXHEALTH

Max Healthcare Institute Q3 FY26 results (Oct–Dec 2025) and concall

Healthcare · Concall AI · Call held 6 Feb 2026

Management summary

  • Max Healthcare delivered its 21st consecutive quarter of YoY growth despite seasonal softness and temporary disruptions from insurance cashless services and regulatory changes.
  • The company continued aggressive expansion with new bed additions and geographic diversification into Western India.

Source: Inve concall analysis and management guidance record.

What they filed

Q3 FY26: revenue up 10.7%, net profit up 25.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue1,868 1,910 2,028 2,135 2,068 +11%
EBITDA499 512 523 575 538 +8%
Net profit239 319 308 491 301 +26%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Guidance & targets

Expansion

  • Pune Hospital Expansion · By 2030 · High confidence 450 beds

Capacity

  • Max Dwarka Expansion Capacity · Near-term · High confidence Additional 260 beds

Source: Inve Guidance Tracker — management targets and direct quotes from the earnings call transcript.

Unlock risks & concerns, Q4 FY26 watchlist, and full call analysis

You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:

  • 3 risks, concerns & management red flags
  • Watchlist triggers for Q4 FY26
  • +1 more guidance target & verbatim management quotes
  • Full section-by-section call narrative

Sign in to use your monthly call allowance.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image